FEATURED ARTICLES
5 Sponsor Contracting Issues That Delay Clinical Trials — And How To Avoid Them
CTA negotiations don’t have to stall study start-up. Learn five sponsor-side contracting issues that cause delays and practical ways to prevent them.
-
The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is Suspect
Starting site work before an enforceable agreement may look like flexibility, but it can drain leverage, create unrecoverable costs, and raise financial reporting and GCP concerns.
-
How AI Will Reshape Study Start-Up
AI can help study start-up teams move from tracking delays to predicting risks—if human judgment, data quality, and governance stay central.
-
Why ING Feels Different
I’ve attended enough clinical trial conferences to know how similar they can feel. ING is different. Its Dive Teams, WhaleTank, and candid conversations are designed to get attendees participating, not just listening. This year, I’m especially interested in an off-the-record regulatory panel that could tackle some of the biggest changes facing clinical research.